Liver and biliary diseases affect more than a billion people worldwide, with high associated
morbidity and mortality. The impact of the intestinal bacterial microbiome on liver diseases
has been well established. However, the fungal microbiome, or mycobiome, has been
overlooked for a long time. Recently, several studies have shed light on the role of the
mycobiome in the development and progression of hepatobiliary diseases. In particular, the
fungal genus Candida has been found to be involved in the pathogenesis of multiple …